| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1Center for Surgical Research, 2Department of Surgery, and 3Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama 35294
Submitted 2 July 2003 ; accepted in final form 19 June 2004
 |
ABSTRACT |
|---|
 TOP ABSTRACT MATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
-estradiol (E2)-treated (0.5 mg sc, 1 wk before T-H) adult male rats. At 2 h after T-H or sham operation, cardiac output, heart rate, mean arterial pressure, positive and negative first derivative of pressure (±dP/dt), stroke volume, and total peripheral resistance were determined. Cardiomyocytes were isolated and divided into two parts: one was used for measurements of intracellular IL-6 levels using fluorescein-activated cell sorting, and the other was used to isolate RNA to determine IL-6 gene expression by quantitative real-time PCR. In addition, cardiac IL-6 protein levels were measured in freshly isolated hearts by Western blotting. Cardiac output, stroke volume, +dP/dt, –dP/dt, and total peripheral resistance were markedly altered after T-H. These parameters, except –dP/dt, improved significantly in the castrated group; however, all these parameters were restored in E2-treated males. Cardiomyocyte IL-6 mRNA expression and intracellular IL-6 production increased after T-H. Cardiac IL-6 protein levels increased after T-H in freshly isolated heart. Castration and E2 treatment attenuated cardiomyocyte intracellular IL-6 levels and cardiac IL-6 protein levels after T-H; however, only E2 treatment attenuated cardiomyocyte IL-6 gene expression. Thus there is an inverse correlation between cardiomyocyte IL-6 levels and cardiac function after T-H. The salutary effects of E2 on cardiac function after T-H may be due in part to decreased IL-6 synthesis in cardiomyocytes.
estrogen; ribonucleic acid; quantitative real-time polymerase chain reaction; Western blot; cytokines; fluorescein-activated cell sorting; interleukin-6
-estradiol (E2) improved/restored the depressed cardiac function (19, 25, 34). Studies also showed that systemic IL-6 levels increased after trauma-hemorrhage, and sustained elevation in IL-6 levels correlated with poor outcome after trauma-hemorrhage and resuscitation (34, 40).
IL-6 is a 21-kDa cytokine that is produced by variety of cells, including fibroblasts, endothelial cells, mononuclear phagocytes, neutrophils, hepatocytes, T and B lymphocytes (31, 45), macrophages (38), and myocytes (3). IL-6 receptor contains two chains: an 
-chain (glycoprotein 80; CD 126), which is specific for IL-6, and a -chain (glycoprotein 130), which is shared with all other members of the IL-6 family, including IL-11, oncostatin M, leukemia inhibitory factor, ciliary neurotrophic factor, and cardiotropin 1 (31). IL-6 is a multifunctional cytokine that affects various cell types. Studies have shown that hypoxia, a condition associated with trauma-hemorrhagic shock, induced the expression of IL-6 mRNA and increased IL-6 production in cardiomyocytes (45). Moreover, IL-6 has been reported to be involved in the pathogenesis of myocardial injury in ischemic heart disease (11) and congestive heart failure (12, 42). The clinical relevance of these effects of IL-6 are supported by a complementary study that reported elevated IL-6 levels in humans after cardiopulmonary bypass, which depressed human cardiac tissue in vitro (13). Studies have also demonstrated that IL-6 mRNA and protein are produced in the lungs, liver, and intestinal tracts of rats subjected to hemorrhagic shock (17, 18). Previous studies have also shown that Kupffer cells (KC) are the major producers of systemic IL-6 after trauma-hemorrhage, because depletion of KC by pretreatment of rats with gadolinium chloride abolished the increase in systemic IL-6 after trauma-hemorrhage (38, 46). Nonetheless, it remains unknown whether local cardiac IL-6 levels increase after trauma-hemorrhage and resuscitation and, if so, whether there is a correlation between cardiac IL-6 levels and cardiac function. We hypothesized that cardiac IL-6 production increases after trauma-hemorrhagic shock and that this increase in IL-6 locally in cardiomyocytes is responsible for producing the depression in cardiac function under those conditions. We also hypothesized that treatment with E2 in male rats will attenuate cardiac local IL-6 production and prevent the depression in cardiac functions after trauma-hemorrhage and resuscitation.
|
MATERIALS AND METHODS |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
60% of the total circulating blood volume. The rats were then maintained at that pressure by return of small volumes of Ringer lactate until 40% of the MBO was returned in the form of Ringer lactate. The animals were then resuscitated with Ringer lactate (4 times the MBO) 90 min after the onset of bleeding via a right femoral venous catheter over 1 h. In a group of males, castration was performed 2 wk before induction of trauma-hemorrhage. Briefly, a 1-cm-long midline incision was performed in the scrotum under isoflurane isolation anesthesia, testes including epididymides in both sides were removed, the stumps were ligated securely, and the scrotum incision was closed. The animals were then returned to cages and allowed free access to food and water. In E2-treated males, 0.5 mg of E2 was administered subcutaneously to each rat 1 wk before induction of trauma-hemorrhage through a tunnel made by a 10-gauge precision trochar under anesthesia with isoflurane inhalation. Animals were then returned to cages and allowed food and water ad libitum. The experiments were performed in adherence to the National Institutes of Health guidelines for the use of experimental animals. The Institutional Animal Care and Use Committee of The University of Alabama at Birmingham approved this project. Determination of plasma levels of sex hormones. Blood samples (2 ml) were collected in EDTA-coated test tubes after the onset of hemorrhage in various trauma-hemorrhage groups and after the measurement of cardiac function via the femoral arterial catheter or the right carotid arterial catheter in sham groups, respectively. Plasma was separated by centrifugation immediately, and the plasma samples were stored at –70°C until assayed for sex hormones. Plasma levels of E2, testosterone, and dihydrotestosterone (DHT) were determined by enzyme immunoassay (EIA) kits: estradiol and testosterone EIA kits (Cayman Chemical, Ann Arbor, MI) and DHT EIA kit (Alpco Diagnostics, Windham, NH), according to the manufacturer's instruction.
Determination of cardiac function. At 2 h after trauma-hemorrhage or sham operation, the animals were anesthetized again with pentobarbital sodium (50 mg/kg ip). Cardiac output (CO) was determined using the indocyanine green (ICG) dilution technique (15). A 2.4-Fr fiber-optic catheter (Hospex Fiberoptics, Chestnut Hill, MA) was inserted into the right carotid artery and advanced to the level of the aortic arch for continuous measurement of ICG concentration by using an in vivo hemoreflectometer (Schwarzer-Picker International, Munich, Germany). A silicone rubber catheter was inserted into the right jugular vein to reach the level of the right atrium. ICG (50 µl, 1 mg/ml) was injected via the right jugular vein catheter. The concentration of ICG was recorded by using a computer-assisted data acquisition program (Asystant+, Asyst Software, Rochester, NY). After the measurement of CO, the right carotid artery was recannulated with PE-50 tubing and connected with a blood pressure analyzer (DigiMed, Louisville, KY). After MAP and HR were recorded, this PE-50 tubing was advanced into the left ventricle and connected to a heart performance analyzer (DigiMed) to monitor and record positive and negative first derivatives of pressure (+dP/dt and –dP/dt). CO, stroke volume (SV), total peripheral resistance (TPR), systemic O2 delivery, and O2 consumption were calculated according to standard equations.
Isolation of cardiomyocytes.
Ventricular myocytes were isolated immediately after the measurement of cardiac function. The heart was quickly removed from the chest and perfused in a retrograde manner via the aorta at 37°C and at a consistent rate (12 ml·min–1·g tissue–1) for 5 min with a Ca2+-free Krebs buffer containing (in mM) 118 NaCl, 4.7 KCl, 25 NaHCO3, 1.2 KH2PO4, 1.2 MgSO4, 10 HEPES, and 11 glucose, gassed with 95% O2-5% CO2. After perfusion, Ca2+-free Krebs buffer was replaced by enzymatic digesting buffer containing Ca2+-free Krebs buffer, collagenase type II (Worthington, Lakewood NJ), 0.1% fat-free BSA, 100 µM CaCl2, and 10 mM taurine and perfused at 37°C at a consistent rate (5 ml·min–1·g tissue–1) for 9 min. When the heart became swollen and hard after 9 min of digestion, the ventricle was removed and cut into small chunks (1 x 1 mm3) and further digested with the incubation buffer containing enzymatic digesting buffer and 2% fat-free BSA in a shaker (60–70 rpm) at 37°C for 10 min. The supernatant containing the dispersed cardiomyocytes was filtered through a 300-µl filter into a 50-ml sterilized tube and gently centrifuged at 500 rpm for 1 min. The upper portion of the supernatant was discarded, 30 ml of BSA-free buffer (Ca2+-free Krebs buffer + 50 µM CaCl2) were added, and the supernatant was centrifuged at 480 rpm for 1 min. The upper portion of the supernatant was again discarded, and 10 ml of cell suspension were carefully layered onto high-BSA (4%) medium and centrifuged (480 rpm for 1 min). The cell pellet was then promptly resuspended in Ca2+ solution (Ca2+ I, II, and III) for Ca2+ restoration. The Ca2+ restoration step was divided into three steps; i.e., 0.125, 0.25, and 0.5 mM Ca2+ for I, II, and III, respectively. Each Ca2+ restoration step lasted for 10 min. The number of cardiomyocytes was then counted by suspension of cardiomyocytes in 0.02% trypan blue under a light microscope. To reduce bacterial and viral contamination, the perfusion setup was washed each day with 70% alcohol and then washed three times with sterilized distilled water before perfusion. All the buffers were filtered (0.2-µm filter) and equilibrated with 95% O2-5% CO2 for 
20 min before it was used.
Isolation of cardiomyocyte RNA.
Immediately after isolation, cardiomyocytes (1.5–2 x 106) were processed for RNA extraction using a NucleoSpin RNA purification kit (BD Biosciences, Palo Alto, CA) according to the manufacturer's instruction. RNA concentration was determined by a spectrophotometer (Smart Spec 300, Bio-Rad). Cardiomyocyte RNA was stored at –80°C until used.
Determination of cardiomyocyte intracellular IL-6 levels.
For measurement of intracellular IL-6, isolated cardiomyocytes (1 x 106) were permeabilized with 0.35 ml (for 1 x 106 cells) of Cytofix/Cytoperm (BD Biosciences) at 4°C for 30 min. After permeabilization, cardiomyocytes were incubated with mouse anti-rat IL-6 antibody (1 µg/ml; Biosource, Camarillo, CA) at 4°C for 30 min and for another 30 min with goat anti-mouse IgG-phycoerythrin (PE, 1 µg/ml; Southern Biotech). For the determination of extracellular IL-6 levels, isolated cardiomyocytes were not permeabilized but were stained successively with mouse anti-rat IL-6 antibody and goat anti-mouse IgG-PE. For background or negative control, the cardiomyocytes were stained with goat IgG-PE in the absence of primary mouse anti-rat IL-6 antibody. Flow cytometric analysis was performed using FACS-CALIBUR (Becton Dickinson, San Jose, CA) to determine cardiomyocyte levels of intracellular and extracellular IL-6 after sham operation or trauma-hemorrhage, and the percentage of gated IL-6-positive cardiomyocyte population was recorded.
Western blotting for measurement of cardiac IL-6 protein levels.
Freshly isolated hearts from each animal (0.2 g) were homogenized in 1 ml of lysis buffer containing 20 mM HEPES, pH 7.9, 1.5 mM MgCl2, 20 mM KCl, 20% glycerol, 0.2 mM EDTA, 2 mM Na3Vo4, 10 mM NaF, 1% Triton X-100, 0.2 mM PMSF, 10 mg/ml aprotinin, and 10 mg/ml leupeptin. Tissue lysates were centrifuged at 10,000 g for 10 min, and the supernatants were stored at –80°C until use. Tissue lysate protein concentrations were assayed (Bio-Rad Laboratories, Hercules, CA), and lysates (30 µg per lane) were analyzed by SDS-12% polyacrylamide gel and transferred to nitrocellulose paper. An equivalent amount of protein from various samples was loaded on the gel. The membranes were immunoblotted with anti-rat IL-6 antibody (Biosource) followed by addition of horseradish peroxidase-conjugated secondary antibody. After the final wash, membranes were probed using enhanced chemiluminescence dye (ECL, Amersham Pharmacia Biotech, Piscataway, NJ) and autoradiographed. The intensity of the bands was determined using densitometric analysis (47). In addition, the membranes were reprobed using mouse monoclonal antiactin antibody (Santa Cruz Biotechnology, Santa Cruz, CA).
Determination of cardiomyocyte IL-6 mRNA expression by quantitative real-time PCR.
Cardiomyocyte IL-6 gene expression was determined by quantitative real-time PCR (QT-PCR). IL-6 primers were designed using the ABI Prism Primer Express Program (Applied Biosystems, Foster City, CA), and amplification of cDNA was performed on an ABI PRISM 7900 HT Sequence Detection System (Applied Biosystems). To perform QT-PCR, all the isolated cardiomyocyte RNA was reverse transcribed into cDNA by addition of TaqMan Gold RT-PCR reagent (Applied Biosystems) and use of an Eppendorf Master Cycler Gradient RT-PCR instrument (Eppendorf, Westbury, NY). A relative quantification (
Ct, where Ct is cycle threshold) method was chosen for QT-PCR. 18S was used for internal control, and cDNA from heart tissue from a rat subjected to 2 h of trauma-hemorrhage was used to calibrate the instrument. A 384-well plate was used for QT-PCR. To each well, a 3-µl aliquot of cDNA, 5 µl of TaqMan Universal PCR Master Mix (Applied Biosystems), 0.5 µl of 20x IL-6 or TNF- primer and probe (Applied Biosystems), and 1.5 µl of water were added (total volume = 10 µl). All the samples were measured in triplicate. Samples were amplified for 1 cycle at 50°C for 2 min and 95°C for 10 min followed by 40 cycles at 95°C for 15 s and 60°C for 1 min. Fluorescence was measured at the end of each cycle and after 40 cycles of reaction; a profile of fluorescence vs. cycle number was obtained. An arbitrary threshold of fluorescence was set within the exponential phase of amplification (reference normalized = 0.1). The cycle at which the amplification of the product exceeded this threshold was determined and designated cycle threshold (Ct). The Ct for the gene of interest ranged from 23 to 31 depending on the gene amplified, whereas the Ct for 18S was between 14 and 16 cycles. The expression of each gene within each sample was normalized against 18S and expressed relative to a calibrator sample using the formula 2–(Ct), as described elsewhere (K. Livak, PE-ABI, Sequence Detector User Bulletin 2). Ct can be defined as follows: [Ctgene of interest (unknown sample) – Ct18S (unknown sample)] – [Ctgene of interest (calibrator sample) – Ct18S (calibrator sample)]. The calibrator sample was designated the most highly expressed time point for each gene of interest and, therefore, has an expression of 1. In view of this, all other data are expressed as the fold expression of this value. Before it was used as an internal control, expression of 18S was verified to be constant across all sampling times. To choose and decide the calibrator sample, preliminary experiments were performed to ensure that amplification efficiencies for the target genes and 18S were equivalent (see PE-ABI, Sequence Detector User Bulletin 2).
Statistical analysis.
Values are means ± SE. One-way ANOVA and Tukey's test were employed for comparison among different groups of animals. The differences were considered significant at P 
0.05.
|
RESULTS |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
|
|
|
|
|
|
|
|
|
|
DISCUSSION |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
Another aspect to consider is whether isolation of cardiomyocytes might introduce artifacts and negatively influence the results. Although we cannot entirely rule out this possibility, we do not believe our results to be isolation artifacts. The reason for this conclusion is that, in the measurement of cardiomyocyte intracellular IL-6 levels by fluorescein-activated cell-sorting analysis, the population of positively gated IL-6 cardiomyocytes was <10% in sham animals, and this population increased significantly after trauma-hemorrhage. Furthermore, cardiomyocyte extracellular IL-6 level was <1%. These results collectively provide strong evidence that the results after trauma-hemorrhage are not isolation artifacts. It could also be argued that the IL-6 results obtained using isolated myocytes should be confirmed with those obtained from the left ventricle. However, the left ventricle contains at least three different types of cells: cardiomyocytes, fibroblasts, and endothelial cells. Thus measurement of IL-6 in the left ventricle would potentially provide the combined results of IL-6 from at least three different cell types, instead of only myocytes. Because the focus of this study was on cardiac contractile function and because cardiomyocytes are responsible for contractile function, our studies examined IL-6 levels only in isolated cardiomyocytes, and not in other cells such as fibroblasts or endothelial cells.
Because we examined only the short-term hemodynamic effects of E2 treatment after trauma-hemorrhage, it could be argued that the effects may be short lived and, thus, may not translate into improvements in long-term survival. Although we have not measured survival rates in this study, our previous results showed that if an agent had a salutary effect early after trauma-hemorrhage and resuscitation, the beneficial effects were sustained for longer periods of time and they also resulted in improved survival rates of animals (33). The present results also showed that the mortality rate was 22% in male rats 2 h after trauma-hemorrhage and resuscitation; however, all castrated and E2-treated males were alive 2 h after trauma-hemorrhage and resuscitation. Furthermore, previous studies showed that the mortality rate was 30% in the vehicle-treated hemorrhaged group and 11% in the E2-treated group (33). In view of this information, it would appear that the observed salutary effects of E2 do not appear to be short term.
Proinflammatory cytokines are considered the key mediators of cellular damage in immune as well as inflammatory responses. Recent studies showed that proinflammatory cytokines also play a role in the myocardium (44). TNF- was the first cytokine that was suggested to be associated with development of congestive heart failure (19, 26, 27, 34). More recently, clinical and basic studies suggested that IL-6 may also be involved in development of congestive heart failure (12, 24, 35). The interest in IL-6 has been prompted by the fact that IL-6, like TNF-, is elevated in patients with congestive heart failure and is cardiodepressive (12, 24, 43). Furthermore, IL-6 and other proinflammatory cytokines are reported to be involved in the pathogenesis of myocardial injury in myocarditis (29) and ischemic heart diseases (32). Ancey et al. (3) showed that cardiomyocytes and fibroblasts are able to spontaneously produce IL-6. Moreover, studies have shown that hypoxia induces the expression of IL-6 mRNA and increases production of IL-6 in cultures of cardiomyocytes (45). The increased IL-6 production at all culture periods appears to be the consequence of fibroblast proliferation and glycoprotein 130 stimulation (3). Although increased IL-6 mRNA expression and production have been noted in congestive heart failure and myocarditis, studies have not been conducted to determine whether expression and production of IL-6 in cardiomyocytes are increased after trauma-hemorrhage and, if so, whether the increase is associated with depressed cardiac function under these conditions.
Little is known regarding the molecular mechanisms that regulate myocardial expression of proinflammatory cytokines. Studies have suggested that adenosine, a breakdown product of ATP, inhibits the release of TNF- and IL-6 by human monocytes through activation of the A2 receptor (7). In isolated cardiomyocytes, adenosine inhibits the expression of TNF- through activation of the A2 receptor but induces robust expression of IL-6 through activation of the A3 and, possibly, A1 receptor (20). Thus the mechanism by which E2 inhibits cardiomyocyte IL-6 production does not appear to be due to the A2 or A3 receptor, because IL-6 production was decreased in those cardiomyocytes. Deshpande et al. (10) demonstrated that E2 attenuates cytokine production by inhibiting activation of the transcription factor NF-
B in murine macrophages. In this regard, our recent studies showed that E2 also inhibits KC IL-6 release, whereas DHT enhanced its production (4, 46). Thus it appears that E2 is capable of downregulating not only KC, but also cardiomyocyte, IL-6 production.
Previous studies from our laboratory showed that cardiovascular and immunologic functions are markedly depressed in males after trauma-hemorrhage but not in proestrus females under those conditions (4, 19). The reason for the diverse cardiovascular and immunologic effects between males and females appears to be high estradiol levels in proestrus (4, 19). Support for this notion also comes from the studies in which the response of ovariectomized females to trauma-hemorrhage was similar to that of males (4, 19, 34). Furthermore, administration of E2 in ovariectomized animals and even in males normalized the depressed cardiovascular and immunologic responses after trauma-hemorrhage (4, 19, 34). In addition, our preliminary findings suggest that levels of cardiomyocyte intracellular IL-6 as well as IL-6 mRNA expression are low in proestrus females with high levels of estrogen. These females do not exhibit cardiac depression 2 h after trauma-hemorrhage (unpublished data). Together, these studies therefore suggest that the local production of IL-6 plays a key role in regulating cardiac function after trauma-hemorrhage.
The precise mechanism of the beneficial effects of E2 and castration on cardiac function after trauma-hemorrhage and resuscitation remains unknown. The present results indicate significant differences in plasma sex hormone levels in normal, castrated, and E2-treated males. The highest plasma levels of androgen (testosterone and DHT) as well as the lowest levels of estradiol were found in normal males. In contrast, the highest estradiol levels were found in E2-treated males. Although the lowest levels of plasma androgens were found in castrated males, plasma levels of estradiol were also low in that group. Because the ovaries are the predominant source of estradiol production in females, the testes and peripheral aromatization of testosterone and DHT account for the low levels of estradiol in males. It appears that not only low circulating levels of estrogen but also high levels of male sex steroids, which include testosterone and DHT, are responsible for depression of organ functions after hemorrhagic shock. In this regard, estradiol has been shown to produce various beneficial effects after circulatory stress (1), and studies have shown that a high level of estrogen in proestrus females and in E2-treated male rats as well as mice produces salutary effects on cardiovascular and immunologic function after trauma-hemorrhage (1, 2, 4, 19, 25, 34).
Our previous studies showed that estrogen's salutary effects on organ functions were evident even 24 h after trauma-hemorrhage and resuscitation (34). The present study demonstrates that the salutary effects of estrogen on cardiovascular function are evident soon, i.e., 2 h, after trauma-hemorrhage and resuscitation. The actions of estrogen have been well characterized and can be divided into rapid nongenomic and slower genomic effects (30). The immediate effects of estrogen are mediated via constitutive nitric oxide (NO) synthase (cNOS) (9, 22), including endothelial NO production, presumably by increasing the expression or activity of the isoform of cNOS (9). The reduced release of endothelium-derived NO under various adverse circulatory conditions is most likely due to the decreased activity of endothelial cNOS (26). In this regard, our previous studies showed that vascular endothelial cell function is depressed early after the onset of trauma-hemorrhagic shock, and administration of L-arginine (the substrate for cNOS) restored the depressed CO (5). Thus it is possible that the beneficial effects of estrogen on cardiovascular function after trauma-hemorrhage are due to the upregulation of cNOS. In this regard, studies have indicated that activation of cNOS after severe shock is beneficial and results in an attenuated inflammatory response (14, 16). The ability of E2 to diminish leukocyte adherence and migration could be another potential mechanism for the improved organ functions in animals with higher estradiol levels (37). Several studies showed that the failure of microcirculatory perfusion after shock was attributed to the enhanced leukocyte-endothelial interaction under those conditions (23). Moreover, it has been shown that estradiol attenuates cytokine production by inhibiting the transcription factor NF-B and inducing expression of the 90-kDa heat shock protein (HSP)-90 in various tissues (10). Our previous studies also showed that induction of HSPs was associated with protective effects under adverse circulatory conditions (33). Thus the normalized organ function after trauma-hemorrhage in E2-treated males may be also due to induction of HSP-90. Although the precise mechanism of beneficial effects of estrogen remains to be clarified, one or more of the above mechanisms could be responsible for the protective effects of E2 observed in the males after trauma-hemorrhage and resuscitation.
Studies have shown that testosterone increases the levels of vascular smooth muscle thromboxane A2 receptors in the aorta (28). Moreover, testosterone treatment enhances the vasoconstrictor response of thromboxane A2 in the coronary circulation (21, 28). Furthermore, it has been shown that testosterone treatment inhibits prostacyclin synthesis in rat aorta smooth cells in culture (36). It is therefore possible that castration, i.e., depletion of testosterone, inhibits the vasoconstrictive actions of thromboxane A2 or enhances release of the vasodilator prostacyclin in the coronary circulation. In addition, it is possible that depletion of androgen by castration enhances the specific cellular effects of other sex hormones such as estradiol in males. Although castration partially improved cardiac function 2 h after trauma-hemorrhage and resuscitation, it did not improve the depressed –dP/dtmax, nor did it attenuate cardiomyocyte IL-6 gene expression. The low levels of plasma estradiol may account for the lack of improvement in these parameters. Yu et al. (47) showed that JAK2/STAT3, not ERK1/2, mediates IL-6-induced activation of inducible NO synthase and decrease in contractility of adult ventricular myocytes. Because we did not measure JAK2/STAT3 or ERK1/2, we fully recognize that additional studies are needed to determine the precise mechanism of the protective effects of castration as well as estrogen on cardiac function after trauma-hemorrhage and resuscitation. Furthermore, although our present study indicates an inverse correlation between IL-6 and cardiac function, a causal relation between these two parameters cannot be established until additional studies using anti-IL-6 antibody are carried out.
In summary, our results suggest that the depressed cardiac functions after trauma-hemorrhage may be due to upregulation of cardiomyocyte IL-6 production. Support for this suggestion comes from our study showing that treatment with E2 in male rats prevented the increase in cardiomyocyte IL-6 production and the depression of cardiac function after trauma-hemorrhage and resuscitation. The results also indicate that castration only partially improved cardiac function after trauma-hemorrhage and resuscitation. Furthermore, administration of estrogen in males attenuated cardiomyocyte IL-6 mRNA expression as well as cardiomyocyte intracellular IL-6 production; however, castration attenuated only cardiomyocyte intracellular IL-6 production. In addition, cardiac IL-6 protein levels increased significantly after trauma-hemorrhage. Nonetheless, castration and E2 treatment prevented the increase in cardiac IL-6 protein levels. These results, taken together, suggest that there is a close correlation between cardiac function and regional IL-6 synthesis after trauma-hemorrhage and resuscitation and that the beneficial effects of E2 on cardiac function after trauma-hemorrhage may be due in part to decreased IL-6 synthesis in the cardiomyocytes.
|
GRANTS |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
|
FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|
REFERENCES |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103: 401–406, 1999.
B activation in murine macrophages. Am J Reprod Immunol 38: 46–54, 1997.
gene and protein expression in adult feline myocardium. Circ Res 81: 187–195, 1997.
by A2- and A3-adenosine receptors. Am J Physiol Heart Circ Physiol 276: H2141–H2147, 1999.
-estradiol following trauma-hemorrhage: direct downregulation of Kupffer cell proinflammatory cytokine production. Cytokine 21: 91–97, 2003.
This article has been cited by other articles:
|
|
 |
|
  S. Yang, S. Hu, J. Chen, M. A. Choudhry, L. W. Rue III, K. I. Bland, and I. H. Chaudry Mechanism of hepatoprotection in proestrus female rats following trauma-hemorrhage: heme oxygenase-1-derived normalization of hepatic inflammatory responses J. Leukoc. Biol., June 1, 2009; 85(6): 1015 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zou, S. Yang, V. Champattanachai, S. Hu, I. H. Chaudry, R. B. Marchase, and J. C. Chatham Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H515 - H523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Chen, S. Yang, S. Hu, M. A. Choudhry, K. I. Bland, and I. H. Chaudry Estrogen prevents intestinal inflammation after trauma-hemorrhage via downregulation of angiotensin II and angiotensin II subtype I receptor Am J Physiol Gastrointest Liver Physiol, November 1, 2008; 295(5): G1131 - G1137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. R. Crisostomo, A. M. Abarbanell, M. Wang, T. Lahm, Y. Wang, and D. R. Meldrum Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1726 - H1735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. I. Spratt, R. S. Kramer, J. R. Morton, F. L. Lucas, K. Becker, and C. Longcope Characterization of a prospective human model for study of the reproductive hormone responses to major illness Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E63 - E69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Sperry and J. P. Minei Gender dimorphism following injury: making the connection from bench to bedside J. Leukoc. Biol., March 1, 2008; 83(3): 499 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Hamilton, L. Lin, Y. Wang, and A. A. Knowlton Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression Physiol Genomics, January 17, 2008; 32(2): 254 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wang, W. Zhang, P. Crisostomo, T. Markel, K. K. Meldrum, X. Y. Fu, and D. R. Meldrum Endothelial STAT3 plays a critical role in generalized myocardial proinflammatory and proapoptotic signaling Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2101 - H2108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-T. Hsu, Y.-C. Hsieh, W. H. Kan, J. G. Chen, M. A. Choudhry, M. G. Schwacha, K. I. Bland, and I. H. Chaudry Role of p38 mitogen-activated protein kinase pathway in estrogen-mediated cardioprotection following trauma-hemorrhage Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2982 - H2987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhang, H.-Y. Wang, R. Bassel-Duby, D. L. Maass, W. E. Johnston, J. W. Horton, and W. Tao Role of interleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2408 - H2416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yang, M. A. Choudhry, Y.-C. Hsieh, S. Hu, L. W. Rue III, K. I. Bland, and I. H. Chaudry Estrus cycle: influence on cardiac function following trauma-hemorrhage Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2807 - H2815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. I. Spratt, J. R. Morton, R. S. Kramer, S. W. Mayo, C. Longcope, and C. P. H. Vary Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E631 - E638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Szalay, T. Shimizu, T. Suzuki, Y.-C. Hsieh, M. A. Choudhry, M. G. Schwacha, K. I. Bland, and I. H. Chaudry Androstenediol administration after trauma-hemorrhage attenuates inflammatory response, reduces organ damage, and improves survival following sepsis Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G260 - G266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Crisostomo, M. Wang, G. M. Wairiuko, E. D. Morrell, and D. R. Meldrum Brief exposure to exogenous testosterone increases death signaling and adversely affects myocardial function after ischemia Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1168 - R1174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Szalay, T. Shimizu, T. Suzuki, H.-P. Yu, M. A. Choudhry, M. G. Schwacha, L. W. Rue III, K. I. Bland, and I. H. Chaudry Estradiol improves cardiac and hepatic function after trauma-hemorrhage: role of enhanced heat shock protein expression Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R812 - R818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Hsieh, S. Yang, M. A. Choudhry, H.-P. Yu, K. I. Bland, M. G. Schwacha, and I. H. Chaudry Flutamide restores cardiac function after trauma-hemorrhage via an estrogen-dependent pathway through upregulation of PGC-1 Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H416 - H423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Hsieh, S. Yang, M. A. Choudhry, H.-P. Yu, L. W. Rue III, K. I. Bland, and I. H. Chaudry PGC-1 upregulation via estrogen receptors: a common mechanism of salutary effects of estrogen and flutamide on heart function after trauma-hemorrhage Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2665 - H2672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Szalay, T. Shimizu, M. G. Schwacha, M. A. Choudhry, L. W. Rue III, K. I. Bland, and I. H. Chaudry Mechanism of salutary effects of estradiol on organ function after trauma-hemorrhage: upregulation of heme oxygenase Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H92 - H98. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
